David R. Stevens, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 6,450 shares at $3.41 ($22K) on 2009-01-09, disclosed to the SEC on 2009-01-13.
Open-market purchase of $22k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.40 | 200 | $680 | 3.1% |
| 2 | $3.41 | 100 | $341 | 1.5% |
| 3 | $3.43 | 3,800 | $13K | 58.8% |
| 4 | $3.44 | 500 | $2K | 7.8% |
| 5 | $3.45 | 1,850 | $6K | 28.8% |
| Total | $3.44 avg | 6,450 |
| $22K |
| 100% |
| Filing → |